SCHEMBL528600

SCHEMBL528600

C=C(C)C(=O)OC(C#N)CCC

nearest known ligand 0.39

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
TSHR P16473 4/20 0.37
THRB P10828 1/20 0.34
EPHX2 P34913 1/20 0.34
HDAC7 Q8WUI4 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7061248 0.88 TSHR (0.49) TSHREPHX2
SCHEMBL11774722 0.88 TSHR (0.49) TSHREPHX2
SCHEMBL530118 0.85 TSHR (0.38) ALDH1A1TSHRTHRB
SCHEMBL8965442 0.81 TSHR (0.36) ALDH1A1TSHREPHX2HDAC7HDAC8
SCHEMBL7175617 0.81 TSHR (0.36) ALDH1A1TSHREPHX2HDAC7HDAC8
SCHEMBL14659615 0.79 HDAC7 (0.33) ALDH1A1TSHREPHX2HDAC7HDAC8
Methacrylic Acid SCHEMBL27993448 0.78 TSHR (0.34) TSHR
Benzene SCHEMBL8964846 0.76 SLC6A3 (0.34) ALDH1A1TSHREPHX2HDAC7HDAC8
SCHEMBL1960574 0.76 HDAC7 (0.33) TSHREPHX2HDAC7HDAC8HDAC6
SCHEMBL22090181 0.76 LMNA (0.34) TSHREPHX2HDAC7HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 589 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060121387-A1 Toner processes XEROX CORPORATION 2006-06-08 US claimed
US-6664017-B1 Document security processes XEROX CORPORATION 2003-12-16 US claimed
US-5385803-A Authentication process XEROX CORPORATION (US) 1995-01-31 US claimed
US-5334471-A Free-flowing toner comprising a mixture of shell-core polymers , low remanence magnetite and light scattering component XEROX CORPORATION (US) 1994-08-02 US claimed
US-5304448-A Encapsulated toner compositions XEROX CORPORATION (US) 1994-04-19 US claimed
US-5223370-A Low gloss toner compositions and processes thereof XEROX CORPORATION (US) 1993-06-29 US claimed
US-5215855-A Encapsulated toner compositions XEROX CORPORATION (US) 1993-06-01 US claimed
US-5204208-A Mixing at least two toners of different dyes or pigments XEROX CORPORATION (US) 1993-04-20 US claimed
US-5175071-A Encapsulated toner composition XEROX CORPORATION (US) 1992-12-29 US claimed
US-5153089-A Encapsulated toner compositions and processes thereof XEROX CORPORATION (US) 1992-10-06 US claimed
US-5153093-A Overcoated encapsulated toner compositions and processes thereof XEROX CORPORATION (US) 1992-10-06 US claimed
US-5147744-A MICR processes with colored encapsulated compositions XEROX CORPORATION (US) 1992-09-15 US claimed
US-5135832-A COLORED TONER COMPOSITIONS XEROX CORPORATION (US) 1992-08-04 US claimed
US-5114819-A Magnetic encapsulated toner compositions XEROX CORPORATION (US) 1992-05-19 US claimed
US-5082757-A Encapsulated toner compositions XEROX CORPORATION (US) 1992-01-21 US claimed
US-5080986-A Magnetic image character recognition processes with encapsulated toners XEROX CORPORATION (US) 1992-01-14 US claimed
US-5077167-A Encapsulated toner compositions XEROX CORPORATION (US) 1991-12-31 US claimed
US-12597609-B2 Positive electrode plate, secondary battery and power consuming device CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2026-04-07 US disclosed
US-5077167-A Encapsulated toner compositions XEROX CORPORATION (US) 1991-12-31 US disclosed
US-4021397-A LATEX, HYDROXYLAMINE SULFATE THE B. F. GOODRICH COMPANY (US) 1977-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12597609-B2 Positive electrode plate, secondary battery and power consuming device SCO2, CACNA2D4, CACNA2D1 ALDH1A1 4272/4885TSHR 2946/4885THRB 1304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.